Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of abdominal hernias.

Journal of the Royal Society of Medicine·2010
Same author

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

Journal of the American Academy of Dermatology·1989
Same author

The prevalence of primary Sjögren's syndrome in a multiple sclerosis population.

Annals of neurology·1989
Same author

Interpretation of single band patterns in CSF protein electrophoresis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1988
Same author

Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.

Neurology·1986
Same author

Nursing care of the multiple sclerosis patient treated with cyclophosphamide.

The Canadian nurse·1985
Same journal

The delayed morbidity of war.

Journal of the Royal Society of Medicine·2026
Same journal

Are medical incapacity and 'fitness to govern' in politics questions of clinical judgement?

Journal of the Royal Society of Medicine·2026
Same journal

The Placebo Effect and Long History of the Habit of Belief. How a Medieval Image Reveals the Power of the Invisible.

Journal of the Royal Society of Medicine·2026
Same journal

For more events and to book online, please visit //www.rsm.ac.uk/events.

Journal of the Royal Society of Medicine·2026
Same journal

Who is responsible when AI kills?

Journal of the Royal Society of Medicine·2026
Same journal

Patient-centred care: is it enough?

Journal of the Royal Society of Medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

Myositis ossificans progressiva

B H Bass

    Journal of the Royal Society of Medicine
    |October 5, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
    09:01

    Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

    Published on: June 5, 2010